propofol has been researched along with Lung, Hyperlucent in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Lung, Hyperlucent: A lung with reduced markings on its chest radiograph and increased areas of transradiancy (hyperlucency). A hyperlucent lung is usually associated with pulmonary emphysema or PNEUMOTHORAX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez Ayechu, M | 1 |
| Castañeda Pascual, M | 1 |
| Zaballos Barcala, N | 1 |
| Unzué Rico, P | 1 |
1 other study available for propofol and Lung, Hyperlucent
| Article | Year |
|---|---|
[Anesthetic implications of Swyer-James syndrome].
Topics: Adolescent; Anesthesia, Intravenous; Asthma; Atracurium; Atropine; Bronchiectasis; Drainage; Fentany | 2006 |